ResearchMoz

Membrane Technology Market in Pharmaceutical, Biopharma and Life Sciences - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2019

Transparency Market Research
Published Date » 2014-03-20
No. Of Pages » 77
 Membrane technology is widely used in various development phases of pharmaceutical, biopharmaceutical and life sciences industries. Membrane technology includes membrane applications from laboratory drug research to large scale pharmaceutical manufacturing. Applications of membrane technology in pharmaceutical, life sciences and biopharmaceutical industries include lab-scale DNA and protein separation and analysis, drug screening, cell culturing and examination, and virus removal. Single-use disposable technique for biopharmaceuticals and stringent environmental regulations are some of the key factors driving demand for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries. Strict quality and safety standards in pharmaceutical and biopharmaceutical...
Table of Content

Chapter 1 Preface 8
1.1 Report Description 8
1.2 Research Methodology 9
1.2.1 Sources 9
1.2.1.1 Secondary Research 9
1.2.1.2 Primary Research 10
1.2.1.3 Assumptions 10

Chapter 2 Executive Summary 11
2.1 Market Snapshot: Global market for membrane technology in pharmaceutical, biopharmaceutical and life science industries (2013 & 2019) 11

Chapter 3 Market Overview 13
3.1 Introduction 13
3.2 Market Drivers and Opportunities 15
3.2.1 Single-use disposable technique for biopharmaceutical 16
3.2.2 Stringent environmental regulations 16
3.2.3 Globally rising pharmaceutical production 17
3.2.4 Business opportunities lie in product innovation/modification 18
3.3 Restraints and Challenges 19
3.3.1 Effects of membrane fouling on membrane technology 19
3.3.2 High capital and operational cost impede market growth 20
3.3.3 Limitations of membrane materials 20

Chapter 4 Market Trends 22
4.1 Product innovation and portfolio expansion 22
4.2 Rising number of mergers, acquisitions and collaborations 23

Chapter 5 Porter’s Five Forces and Market Attractiveness Analysis 24
5.1 Bargaining power of suppliers 24
5.2 Bargaining power of buyers 25
5.3 Threat of new entrants 25
5.4 Threat from substitutes 25
5.5 Degree of competition 25
5.6 Market Attractiveness Analysis: Global market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries, by geography 26

Chapter 6 Global Market Size and Forecast 28

Chapter 7 Technology Segment Analysis 33
7.1 Ultrafiltration 33
7.2 Microfiltration 35
7.3 Nanofiltration 37
7.4 Chromatography 39

Chapter 8 Regional Analysis 42
8.1 Scenario in North America 42
8.2 Scenario in Europe 44
8.3 Scenario in Asia 48
8.4 Rest of the World 51

Chapter 9 Competitive Landscape 53

Chapter 10 Company Profiles 58
10.1.1 Overview 58
10.1.2 Products & Segments 58
10.1.3 Financial Performance 59
10.2 Sartorius 60
10.2.1 Overview 60
10.2.2 Products & Segments 60
10.2.3 Financial Performance 61
10.3 3M Company 62
10.3.1 Overview 62
10.3.2 Products & Segments 62
10.3.3 Financial Performance 63
10.4 Merck Millipore 64
10.4.1 Overview 64
10.4.2 Products & Segments 64
10.4.3 Financial Performance 64
10.5 GE Healthcare Life Sciences 66
10.5.1 Overview 66
10.5.2 Products & Segments 66
10.5.3 Financial Performance 67
10.6 Koch Membrane System 68
10.6.1 Overview 68
10.6.2 Products & Segments 68
10.6.3 Financial Performance 69
10.7 Novasep 70
10.7.1 Overview 70
10.7.2 Products & Segments 70
10.7.3 Financial Performance 71
10.8 Trisep Corporation 72
10.8.1 Overview 72
10.8.2 Products & Segments 72
10.8.3 Financial Performance 73
10.9 Amazon Filters 74
10.9.1 Overview 74
10.9.2 Products & Segments 74
10.9.3 Financial Performance 74
10.10 Advantec MFS 75
10.10.1 Overview 75
10.10.2 Products & Segments 75
10.10.3 Financial Performance 76


List of Tables

TABLE 1 Market Snapshot: Global market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries (2014 & 2019) 11
TABLE 2 Major products of membrane technology and their application 14
TABLE 3 Drivers for global market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries: Impact analysis 15
TABLE 4 Some of the major products innovation/modifications 19
TABLE 5 Restraints for global market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industry: Impact analysis 19
TABLE 6 Some of the major products launched by companies (2012-2013) 22
TABLE 7 Some of the major mergers, acquisitions and collaborations (2012-2013) 23
TABLE 8 Global market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries size, by segment 2009-2013 (USD million) 28
TABLE 9 Global market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industry size, by segment 2014-2019 ($ million) 29
TABLE 10 Global market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries size, by geography 2009-2013 (USD million) 30
TABLE 11 Global market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries size, by geography 2014-2019 (USD million) 31
TABLE 12 Global market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries size, by technology 2009-2013 (USD million) 31
TABLE 13 Global market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries size, by technology 2014-2019 (USD million) 32
TABLE 14 Global market of ultrafiltration in pharmaceutical, biopharmaceutical and life sciences industries size, by geography 2009-2013 (USD million) 33
TABLE 15 Global market of ultrafiltration in pharmaceutical, biopharmaceutical and life sciences industries size, by geography 2014-2019 (USD million) 34
TABLE 16 Global market of microfiltration in pharmaceutical, biopharmaceutical and life sciences industries size, by geography 2009-2013 (USD million) 36
TABLE 17 Global market of microfiltration in pharmaceutical, biopharmaceutical and life sciences industries size, by geography 2014-2019 (USD million) 37
TABLE 18 Global market of nanofiltration in pharmaceutical, biopharmaceutical and life sciences industries size, by geography 2009-2013 (USD million) 38
TABLE 19 Global market of nanofiltration in pharmaceutical, biopharmaceutical and life sciences industry size, by geography 2014-2019 ($ million) 39
TABLE 20 Global market of chromatography in pharmaceutical, biopharmaceutical and life sciences industries size, by geography 2009-2013 (USD million) 40
TABLE 21 Global market of chromatography in pharmaceutical, biopharmaceutical and life sciences industries size, by geography 2014-2019 (USD million) 40
TABLE 22 The North American market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries, by geography, 2009-2013 (USD million) 43
TABLE 23 The North American market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries, by geography 2014-2019 (USD million) 44
TABLE 24 Pharmaceutical industry research and development expenditure in European countries in 2011 45
TABLE 25 Pharmaceutical market size in European countries in 2011 45
TABLE 26 The European market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries, by geography 2009-2013 (USD million) 47
TABLE 27 The European market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries size, by geography 2014-2019 (USD million) 48
TABLE 28 The Asian market size of membrane technology in pharmaceutical, biopharmaceutical and life sciences industries size, by geography 2009-2013 (USD million) 50
TABLE 29 The Asian market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries, by geography 2014-2019 (USD million) 51
TABLE 30 Pharmaceutical market size of Latin America, Australia and Africa in 2012 (USD billion) 52
TABLE 31 Recent developments – Major product launches (2011-January 2014) 55
TABLE 32 Recent developments – Geographic expansion (2012-January 2014) 56
TABLE 33 Recent developments – Mergers and acquisitions for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries (2011-January 2014) 57

List of Figures


FIG. 1 Membrane technology usage in pharmaceutical, biopharmaceutical and life sciences industries 14
FIG. 2 Global pharmaceutical market size, 2011 – 2020 (USD million) 18
FIG. 3 Global market for membrane technology in pharmaceutical, biopharmaceutical and life science industries: Porter’s five forces analysis 24
FIG. 4 Market attractiveness analysis: Global market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries, by geography 27
FIG. 5 Global market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries size, by segment 2013 & 2019 28
FIG. 6 Global market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries size, by geography in 2013 & 2019 30
FIG. 7 Global market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries size, by technology in 2013 & 2019 31
FIG. 8 Global market for ultrafiltration in pharmaceutical, biopharmaceutical and life sciences industries size, by geography in 2013 & 2019 33
FIG. 9 Global market for microfiltration in pharmaceutical, biopharmaceutical and life sciences industries size, by geography in 2013 & 2019 36
FIG. 10 Global market for nanofiltration in pharmaceutical/biopharmaceutical/life science industry size, by geography in 2013 & 2019 38
FIG. 11 Global market for chromatography in pharmaceutical, biopharmaceutical and life sciences industries size, by geography in 2013 & 2019 39
FIG. 12 The North American market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries, by geography, in 2013 43
FIG. 13 The European market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries, by geography in 2013 46
FIG. 14 The Asian market for membrane technology in pharmaceutical, biopharmaceutical, life science industries, by geography in 2013 49
FIG. 15 Competitive landscape of membrane technology market in pharmaceutical, biopharmaceutical and life sciences industries 53
FIG. 16 Strategic developments in membrane technology market for pharmaceutical, biopharmaceutical and life sciences industries (2011- January 2014) 54

Upcoming Reports:

Poland: hydrochloric acid market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the hydrochloric acid market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the hydrochloric acid market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate...
Super Active-Matrix Organic Light-Emitting Diode (SAMOLED) Market - Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth And Forecast, 2013 - 2019
By - Transparency Market Research
Active-matrix organic light emitting diode (AMOLED) is a growing technology currently used in televisions and mobile devices. AMOLED is a particular type of display technology with a thin flexible film. Organic compounds combine to form electroluminescent material in this display technology, which is used underneath the addressing of pixels. Samsung promoted their description of this AMOLED technology as super AMOLED, thus called as SAMOLED.  SAMOLED market across the globe is expected to witness double digit growth rate by the year 2019 owing to numerous advantageous features...
Ureter Cancer Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
By - Transparency Market Research
Ureter cancer or renal pelvis cancer represents a cancer type affecting the kidney’s pelvis (tube passing the urine from kidney to the bladder). These cancers account for around five percent of all the cancer types related to upper urinary tract and kidney. The occurrence of ureter cancer is more common in men (aged more than 65 years) than women. Ureter or renal pelvis cancer tumors are usually transitional cell cancers and around ten percent of the tumors are squamous cell cancers. The exact causes of ureter cancer is not known, however chronic irritation in the kidney due to...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Pepsi Limon, A Brand New Addition to the Pepsi Portfolio
May 22, 2015  
To add a new dose of excitement to its cola offering, Pepsi has come up with the all new Pepsi Limon. This is a new flavored cola, which according to the company is manufactured with just the appropriate amount of real lime juice. The idea for the drink was inspired from the escalating preference of the Hispanic consumers. To satisfy the taste urges of the consumers, the new Pepsi Limon will...
Chinese Everbright Healthcare Fund to Acquire U.S. Firm Ambrx
May 22, 2015  
A group led by Chinese healthcare fund Everbright has chalked out details to buy U.S. based biotechnology firm Ambrx for an amount which in undisclosed. The deal, recently announces, is inclusive of other healthcare companies in mainland which are WuXi Pharma Tech and Shanghai Fosun Pharmaceutical, and investment company HOPU Investments.  The deal, which requires...
India’s Auto Exports Register Record High Figures in 2014-15
May 21, 2015  
In the fiscal year 2014-15, Indian factories exported a record number of 3.5 million vehicles, which is 15% higher than what they managed a year back. However, domestic sales rose by only 5% since last financial year, with 2.6 million units being sold.  Exports of utility vehicles, commercial vehicles, cars and two- wheelers have increased every year since 2000. But domestic car...
Turkey’s Labor Dispute Affects Ford’s Production
May 21, 2015  
With the ongoing labor dispute in Turkey, Ford’s Turkish manufacturing facility has been hit. Ford Otosan, a joint venture between the company and Turkey’s Koc Holding, mentioned that due to supply problems, production has been temporary stalled at its plants located at Yenikoy and Golcuk in northwestern part of the country. Earlier this week, production at Tofas and Oyak Renault,...
International Automakers Slashing Prices in China
May 21, 2015  
With a slowing Chinese economy, the international automakers are cutting prices of vehicles to be sold in the nation. This has hit the profit margins of the automakers who are struggling with a slowdown in demand.  Last week saw Ford Motor Co. and General Motors slashing their prices on Chinese models. It closely follows rival Volkswagen AG’s move last month to offer...